• Prmt1–Ddx17 Axis in Osteoblast Differentiation

  2026-08-09

  The reference study proposes a mechanistic link between PRMT1-dependent arginine methylation, Ddx17 protein stability, and Sh2b1 alternative splicing during osteoblast differentiation. Its findings position the PRMT1–Ddx17–Sh2b1 pathway as a candidate regulator of impaired bone formation, while the cell-based design also highlights the need to separate proliferation, viability, and lineage-specific differentiation readouts.

• EZ Cap™ mCherry mRNA: Cap 1 Reporter Guide

  2026-08-08

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a Cap 1 red fluorescent protein mRNA for transient reporter expression, cell tracking, and localization studies. Its modified nucleotides, approximately 100-nucleotide poly(A) tail, and defined storage formulation are designed to support mRNA stability and translation enhancement while reducing RNA-mediated innate immune activation.

• ERK Links IFNγ to Melanoma Cell Death

  2026-08-07

  Champhekar et al. identify ERK as a major mediator of IFNγ-induced apoptosis in melanoma, connecting canonical IFNγ–STAT1 signaling to a stress program involving DR5 and NOXA. Complementary chemical-genetic, CRISPR, transcriptomic, imaging, and apoptosis assays show that this mechanism operates across diverse melanoma genotypes but is not universal.

• Anlotinib Hydrochloride: Precision Angiogenesis Inhibition f

  2026-08-07

  Explore how Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, transforms angiogenesis research with unmatched selectivity and functional assay reliability. This article provides a unique deep dive into its pharmacological precision and evidence-based practical protocols.

• Anlotinib in IADSRCT: First Clinical Case and Mechanistic Co

  2026-08-06

  This article examines the first documented case of anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in the treatment of intra-abdominal desmoplastic small round cell tumor (IADSRCT). The report details significant clinical response and mechanistic implications for targeting angiogenesis in aggressive sarcomas, with discussion of experimental design and translational potential.

• Translating Angiogenesis Blockade: Anlotinib Hydrochloride i

  2026-08-06

  Explore how Anlotinib hydrochloride, a next-generation multi-target tyrosine kinase inhibitor, is redefining translational cancer research by integrating mechanistic precision with strategic assay guidance. This thought-leadership article synthesizes current evidence, experimental design parameters, and product intelligence to empower researchers targeting angiogenesis and tumor proliferation.

• Vitamin D/VDR Pathway Enhances Endometrial Decidualization i

  2026-08-05

  This study elucidates how 1,25-dihydroxy vitamin D3, via vitamin D receptor (VDR) signaling, promotes human endometrial stromal cell decidualization by regulating estrogen synthesis and key differentiation markers. Findings provide a mechanistic foundation for exploring vitamin D's role in reproductive health and endometrial receptivity.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Application

  2026-08-05

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for specific detection of HMGB1 protein in human, mouse, and rat samples for research purposes, supporting workflows such as Western blot, immunohistochemistry, and flow cytometry. It is not validated for diagnostic or therapeutic use and should only be used under controlled laboratory conditions within research applications.

• Pravastatin Sodium: Advanced Workflows for Cholesterol Biosy

  2026-08-04

  Pravastatin sodium empowers precision research into cholesterol metabolism, LDL reduction, and drug-transporter interplay. This guide delivers optimized protocols, troubleshooting strategies, and actionable insights for maximizing experimental reproducibility and translational value.

• Anlotinib Hydrochloride: Precision in Angiogenesis Assays

  2026-08-04

  Explore the scientific depth of Anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor for angiogenesis and tumor proliferation assays. This article uniquely dissects assay design, protocol nuances, and practical research decisions for advanced cancer research.

• Tioconazole: Mechanistic Leverage and Strategy in Translatio

  2026-08-03

  This article explores how Tioconazole, a research-grade antifungal medication from APExBIO, serves as both a mechanistic probe and strategic asset in antifungal drug development. By integrating classic and emerging mechanistic insights—including ergosterol biosynthesis inhibition, cytochrome P450 targeting, and the interplay of fungal metabolism with genomic stability—the piece offers actionable guidance for translational researchers. Drawing on recent advances in metabolic-genomic crosstalk and leveraging external research on energy deficiency-mediated DNA repair, it positions Tioconazole as a model compound for innovation in antifungal discovery pipelines, while critically evaluating the opportunities and boundaries of cross-domain findings.

• Genotoxicity and Cytotoxicity of Heat-Not-Burn Products vs.

  2026-08-03

  This study rigorously compares the genotoxic and cytotoxic profiles of a heat-not-burn product (HnBP) with conventional cigarettes using both in vivo and in vitro models. The results indicate that HnBPs, while not risk-free, exhibit significantly reduced genotoxicity and cytotoxicity relative to conventional cigarette smoke, providing insight for toxicological assessment and regulatory strategies.

• Gepotidacin's Unique Gyrase Inhibition Illuminates Antibioti

  2026-08-02

  Gibson et al. reveal that gepotidacin inhibits Staphylococcus aureus DNA gyrase through a distinct single-strand DNA cleavage mechanism, differing fundamentally from fluoroquinolone antibiotics. These mechanistic insights reshape our understanding of gyrase inhibition and guide future antibiotic design as well as research into antibiotic toxicity and resistance.

• Precision Apoptosis Detection: Mechanistic Insight and Trans

  2026-08-01

  This thought-leadership article provides translational researchers with a mechanistic and strategic framework for apoptosis detection, focusing on the TUNEL Apoptosis Detection Kit (DAB) from APExBIO. Integrating key findings from recent oxidative stress research and leveraging cross-domain expertise, the article offers actionable protocol guidance, competitive landscape analysis, and a visionary outlook for programmed cell death studies.

• Anlotinib in IADSRCT: Case Evidence and Translational Resear

  2026-07-31

  The referenced case report demonstrates, for the first time, clinical benefit of anlotinib—a multi-target tyrosine kinase inhibitor—in treating metastatic intra-abdominal desmoplastic small round cell tumor (IADSRCT). This article contextualizes the study’s findings in the broader landscape of anti-angiogenic research and highlights key experimental considerations for researchers exploring anlotinib’s mechanisms.

15291 records 1/1020 page Next 12345 下5页 Last page